Health-related content. Aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before making decisions. .

InfantRisk HCP is a medical reference tool developed by Texas Tech University Health Sciences Center to provide clinicians with evidence-based safety data on medications during pregnancy and breastfeeding. The app features a proprietary drug rating system and a database of over 70,000 products to assist healthcare professionals in clinical decision-making. It serves as a professional-grade counterpart to the consumer-facing MommyMeds app.

Overview · Full Intel report in progress

The App DNA

What makes this app unique?

For Healthcare professionals seeking evidence-based information on medication safety for pregnant and breastfeeding patients.

What does it look like?

Key features

Drug Rating Systemstandard

Provides an intuitive safety scale from 1 (safest) to 5 (most hazardous) for pregnancy and lactation.

Medication Databasestandard

Allows users to search through a library of over 70,000 medication products.

Evidence-Based Summariesstandard

Offers concise clinical summaries for each medication to support informed decision-making.

Comparison Toolsstandard

Enables users to compare safety ratings for drugs categorized by indication or drug class.

How much does it cost?

subscription

Velocity

Maintenance developmentShow more...

5 versions in history. Development pace: maintenance.

See all version history

Who built it?

Texas Tech University Health Sciences Center

2 apps tracked · Medical

MommyMedsMommyMeds
Explore the full publisher profile

User Sentiment

What do users think recently?

How are ratings & reviews evolving?

App Store
4.58 · 147
Google Play
2.37 · 93

Not enough recent reviews to extract reliable themes yet.

Read the full review analysis

Competition

Competitive landscape for InfantRisk HCP

How's the Medical market?

The rivals identified

The Analyst's Read

Key takeaways for InfantRisk HCP

Where is it heading?

Bottom line

While the app is a highly regarded clinical resource, recent user feedback highlights significant technical instability and subscription fulfillment issues.

Report last updated

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with automated quality gates, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by InfantRisk HCP, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

Cite this report

Marlvel.ai. “InfantRisk HCP Intelligence Report.” Updated Apr 19, 2026. https://marlvel.ai/apps/con-irc-hcp2

Agent Markdown (.md)See methodologyContact support

Data licensed under CC-BY-NC 4.0